Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Today's Featured Article Oklo: The Bottom Is In, and the Upside Potential Is NuclearSubmitted by Thomas Hughes. First Published: 3/19/2026. 
Key Points - Oklo's FY2025 update revealed progress, and the market liked it; the diversification strategy is progressing.
- Analysts responded favorably, affirming the forecast for a 50% stock price increase.
- Short-covering and institutional accumulation align with a technical bottom, setting this market up to sustain a rebound in 2026.
- Special Report: Have $500? Invest in Elon's AI Masterplan
Oklo Inc. (NYSE: OKLO) faces headwinds, including a lack of revenue and profits, but that hasn't fazed the market. The company's fiscal year 2025 (FY2025) progress report and updates indicate it is on track to meet long‑term goals and market expectations. The market response — including analyst updates after the release — makes the point: near‑term revenue isn't the focus when the longer‑term opportunity looks compelling. Analysts Focus on Oklo's Long‑Term Opportunity MarketBeat tracked roughly half a dozen revisions in the first 12 hours after the release. Those included one price‑target reduction, several affirmed ratings and targets, and no downgrades. "What's happening in NYC will spread..." Last year I ran for Mayor of New York City... and lost to a 34-year-old Democratic Socialist. Now he wants to spend $70 million just to study government-run grocery stores. Raise property taxes 9.5%. And hike taxes on every corporation and high earner. I've spent 30 years on Wall Street. And I'm convinced what's starting in New York is just the beginning. I've put together a free analysis explaining exactly what's coming, and what you can do about it. Read it here. The activity fits with an ongoing trend of rising coverage, a steady Moderate Buy consensus, a 58% buy‑side bias, and an upward drift in price targets. Price targets matter here: consensus implies more than 50% upside from mid‑March lows. Analysts expressed concern about the 2025 results but remain primarily focused on the long‑term opportunity and progress with Nuclear Regulatory Commission licensing. Oklo's subsidiary Atomic Alchemy received its first license, authorizing the receipt, possession, storage, processing, repackaging, and distribution of up to two curies of radium‑226 (roughly two grams). Two grams isn't much, and radium‑226 has limited value on its own. Once used in medical applications, it is now cumbersome to handle and remediate. But radium‑226 is a precursor for actinium production, and actinium (particularly actinium‑225) is extremely valuable for specialized cancer treatments — with costs commonly cited around $20,000 per dose. The implication for investors is that Oklo's diversification strategy is validated and that a revenue stream has been opened. It may take a few quarters for meaningful revenue to appear, but that income could arrive well before the full commercialization of its core nuclear reactor technologies. Institutional and Short‑Selling Data Suggest the Bottom Is In Institutional and short‑selling data point toward a potential bottom for Oklo stock. Short interest remains elevated — near 15% as of early March — but it has fallen from its peak around Oklo's October 2025 highs and is likely to decline further in upcoming reports. Institutional activity moved in the opposite direction, increasing after Oklo's Q2 2025 slide and reaching record levels in early 2026. As of now, institutions own roughly 85% of outstanding shares, which provides solid support. They are accumulating at an estimated pace of $3 purchased for every $1 sold. If those trends continue, the float available to trade could shrink significantly over the coming months, supporting upward price action and increasing the potential for a short squeeze if a catalytic news event occurs. Dilutive Headwinds Ease in 2026 Shareholder dilution was a meaningful headwind in 2025 but has eased entering 2026. The company's share count is about 50% higher year‑over‑year, and the balance sheet remains well capitalized. FY2026 plans suggest Oklo has sufficient capital to operate for roughly two years at the current project burn rate, creating a window for secondary revenue streams — such as the isotope business — to develop. The trade‑off is that profitability isn't expected until 2030, so additional funding will likely be required later. The technical setup looks constructive. Oklo's stock is still well below its highs and appeared overextended in March, but several indicators have turned positive. The MACD has moved bullish, and the stochastic oscillator has followed, signaling a strong buy at current levels. Whether the market follows through may take time; a lack of revenue and profits remains a heavy burden for valuation. The biggest risk is execution and delay. The market is pricing in robust future growth — valuing the stock at over 100× initial‑year earnings — and may be intolerant of setbacks. In that case, Oklo could experience heightened volatility regardless of the timing of any rebound. | 
